Skip to main content

Table 1 Demonstrates the statistical significance of IPSS and QoL changes post sclerotherapy

From: Role of varicocele sclerotherapy in the management of benign prostatic hyperplasia and its associated lower urinary tract symptoms (pilot study)

  Pre Post Test value P value Sig
No. = 36 No. = 36
IPSS scores
 Median (IQR) 19 (15–22.5) 17 (7–19) − 2.425 0.015 S
 Range 7–30 6–35
IPSS grades
 Mild (1–7) 3 (8.3%) 9 (25.0%) 13.130* 0.004 HS
 Moderate (8–19) 18 (50.0%) 15 (41.7%)
 Severe (20–35) 15 (41.7%) 6 (16.7%)
 NA 0 (0.0%) 6 (16.7%)
QOL
 Median (IQR) 5 (4–6) 4 (4–6) − 2.546 0.011 S
 Range 3–6 2–6
  1. P value > 0.05: non significant (NS); P value < 0.05: significant (S); P value < 0.01: highly significant (HS)
  2. *Chi-square test
  3. Wilcoxon Rank test